Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Alopecia areata patients have lower vitamin D and slightly lower copper levels, so these should be checked.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Researchers found key regions in the mouse hairless gene that control its activity in skin and brain cells, affecting hair follicle function.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Doctors vary in how they initially test for PCOS, but most agree on using oral contraceptives and lifestyle changes as first treatments.

Men have more severe COVID-19 outcomes than women.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Photodynamic Therapy is an effective treatment for mild to severe acne.

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Fetal environments contain various chemicals that may disrupt hormones.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The document concludes that more research is needed to fully understand the causes of PCOS.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.